| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |